Concepts (67)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Attention Deficit Disorder with Hyperactivity | 4 | 2019 | 189 | 1.200 |
Why?
|
| Anemia, Sickle Cell | 6 | 2012 | 364 | 0.850 |
Why?
|
| Epilepsy | 2 | 2017 | 336 | 0.840 |
Why?
|
| Central Nervous System Stimulants | 4 | 2019 | 221 | 0.830 |
Why?
|
| Cognition Disorders | 3 | 2011 | 342 | 0.480 |
Why?
|
| Neuropsychological Tests | 4 | 2011 | 517 | 0.350 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 3 | 2006 | 99 | 0.340 |
Why?
|
| Child | 11 | 2021 | 6405 | 0.310 |
Why?
|
| Methylphenidate | 3 | 2019 | 97 | 0.250 |
Why?
|
| Adolescent | 10 | 2021 | 8912 | 0.250 |
Why?
|
| Cerebrovascular Disorders | 1 | 2004 | 182 | 0.220 |
Why?
|
| Brain Damage, Chronic | 1 | 2001 | 25 | 0.200 |
Why?
|
| Cerebrovascular Circulation | 1 | 2003 | 296 | 0.200 |
Why?
|
| Lupus Vasculitis, Central Nervous System | 1 | 2021 | 14 | 0.190 |
Why?
|
| Cognition | 2 | 2012 | 513 | 0.190 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 1 | 2019 | 29 | 0.170 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2019 | 57 | 0.170 |
Why?
|
| Attention | 2 | 2012 | 225 | 0.150 |
Why?
|
| Female | 10 | 2021 | 38074 | 0.140 |
Why?
|
| Neurologic Examination | 1 | 2016 | 107 | 0.140 |
Why?
|
| Male | 9 | 2021 | 37321 | 0.130 |
Why?
|
| Drugs, Generic | 1 | 2015 | 17 | 0.130 |
Why?
|
| Ambulatory Care | 1 | 2016 | 340 | 0.120 |
Why?
|
| Child, Preschool | 2 | 2019 | 3187 | 0.110 |
Why?
|
| Humans | 12 | 2021 | 68618 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 1745 | 0.110 |
Why?
|
| Social Adjustment | 1 | 2012 | 74 | 0.100 |
Why?
|
| Treatment Outcome | 4 | 2017 | 7029 | 0.100 |
Why?
|
| Pain Management | 1 | 2012 | 186 | 0.090 |
Why?
|
| Health Education | 1 | 2012 | 279 | 0.090 |
Why?
|
| Pediatrics | 1 | 2011 | 341 | 0.080 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2012 | 756 | 0.070 |
Why?
|
| Intelligence Tests | 1 | 2006 | 32 | 0.070 |
Why?
|
| Educational Status | 1 | 2006 | 273 | 0.060 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2006 | 181 | 0.060 |
Why?
|
| Psychomotor Performance | 1 | 2006 | 213 | 0.060 |
Why?
|
| Memory | 1 | 2006 | 214 | 0.060 |
Why?
|
| Quality of Life | 1 | 2012 | 1515 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 2279 | 0.060 |
Why?
|
| Intelligence | 1 | 2003 | 45 | 0.060 |
Why?
|
| Psychological Tests | 1 | 2003 | 96 | 0.060 |
Why?
|
| Brain | 2 | 2006 | 2176 | 0.050 |
Why?
|
| Blood Flow Velocity | 1 | 2003 | 172 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2006 | 1465 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2003 | 737 | 0.050 |
Why?
|
| Cerebral Infarction | 1 | 2001 | 103 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 1046 | 0.040 |
Why?
|
| Antibodies, Antinuclear | 1 | 2021 | 171 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2003 | 955 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2001 | 201 | 0.040 |
Why?
|
| Amphetamine | 1 | 2019 | 77 | 0.040 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2021 | 266 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2021 | 434 | 0.040 |
Why?
|
| Insurance, Health | 1 | 2019 | 201 | 0.040 |
Why?
|
| Autism Spectrum Disorder | 1 | 2019 | 111 | 0.040 |
Why?
|
| Medicaid | 1 | 2019 | 302 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 2223 | 0.040 |
Why?
|
| Therapeutic Equivalency | 1 | 2015 | 21 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 504 | 0.030 |
Why?
|
| Age Factors | 1 | 2019 | 1864 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2015 | 411 | 0.030 |
Why?
|
| Reaction Time | 1 | 2012 | 170 | 0.020 |
Why?
|
| Pain | 1 | 2012 | 472 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2012 | 1738 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 1342 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 7277 | 0.020 |
Why?
|
| United States | 1 | 2019 | 7367 | 0.020 |
Why?
|